These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 9589805

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Lymphocyte subpopulations, neopterin, and beta-2-microglobulin: relationship with clinical stage, risk of progression to AIDS and presence of active infection in HIV infection].
    Antón F, Labarga P, Pinilla J, Soto MJ, Leoz A, del Cura J, Borque L, Milazzo A.
    Enferm Infecc Microbiol Clin; 1993; 11(7):373-7. PubMed ID: 8104488
    [Abstract] [Full Text] [Related]

  • 4. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
    AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
    [Abstract] [Full Text] [Related]

  • 5. Improvement of the predictive value of CD4+ lymphocyte count by beta 2-microglobulin, immunoglobulin A and erythrocyte sedimentation rate. The Multicentre Cohort Study Group.
    Schwartländer B, Bek B, Skarabis H, Koch J, Burkowitz J, Koch MA.
    AIDS; 1993 Jun; 7(6):813-21. PubMed ID: 8103341
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Serum neopterin and beta2-microglobulin concentration as "prognostic markers" of AIDS].
    Halota W, Jaruga B, Pawłowska M.
    Pol Merkur Lekarski; 2002 Aug; 13(74):126-8. PubMed ID: 12420343
    [Abstract] [Full Text] [Related]

  • 8. Beta 2-microglobulin and immunoglobulins are more useful markers of disease progression in HIV than neopterin and adenosine deaminase.
    Martínez-Brú C, Cortés M, Planella T, Barrio J, Cadafalch J, Domingo P, Fuster M, Sambeat MA, González-Sastre F.
    Ann Clin Biochem; 1999 Sep; 36 ( Pt 5)():601-8. PubMed ID: 10505209
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical and laboratory predictors of survival in Gambian patients with symptomatic HIV-1 or HIV-2 infection.
    Whittle H, Egboga A, Todd J, Corrah T, Wilkins A, Demba E, Morgan G, Rolfe M, Berry N, Tedder R.
    AIDS; 1992 Jul; 6(7):685-9. PubMed ID: 1354448
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Serum adenosine deaminase in human immunodeficiency virus infection. Its relationship with CD4+ lymphocytes and beta 2-microglobulin].
    Iñigo MA, Ruiz López de Tejada M, Torres-Tortosa M, Sánchez-Porto A, Ugarte I, García de Lomas E, Morán Nestares A.
    Med Clin (Barc); 1992 Dec 12; 99(20):766-8. PubMed ID: 1361013
    [Abstract] [Full Text] [Related]

  • 13. Immunologic marker paths for seroconversion: single determinations of immunoglobulin A and beta 2-microglobulin are not adequate to estimate time of HIV infection. Multicohort Analysis Project Workshop. Part II.
    AIDS; 1994 Jul 12; 8(7):923-33. PubMed ID: 7946101
    [Abstract] [Full Text] [Related]

  • 14. Use of beta 2-microglobulin level and CD4 lymphocyte count to predict development of acquired immunodeficiency syndrome in persons with human immunodeficiency virus infection.
    Anderson RE, Lang W, Shiboski S, Royce R, Jewell N, Winkelstein W.
    Arch Intern Med; 1990 Jan 12; 150(1):73-7. PubMed ID: 1967523
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prognostic value of adenosine deaminase compared to other markers for progression to acquired immunodeficiency syndrome among intravenous drug users.
    Casoli C, Lisa A, Magnani G, Starcich R, Fiaccadori F, Bertazzoni U, Zei G.
    J Med Virol; 1995 Feb 12; 45(2):203-10. PubMed ID: 7775940
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Early levels of CD4, neopterin, and beta 2-microglobulin indicate future disease progression.
    Shi M, Taylor JM, Fahey JL, Hoover DR, Muñoz A, Kingsley LA.
    J Clin Immunol; 1997 Jan 12; 17(1):43-52. PubMed ID: 9049785
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.